Compare · ELIQ vs TMO
ELIQ vs TMO
Side-by-side comparison of Electriq Power Holdings Inc. (ELIQ) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- ELIQ operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO carries a market cap of $222.97B.
- TMO has hit the wire 14 times in the past 4 weeks while ELIQ has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 0 for ELIQ).
- Company
- Electriq Power Holdings Inc.
- Thermo Fisher Scientific Inc
- Price
- $0.28-5.36%
- $605.14+0.33%
- Market cap
- -
- $222.97B
- 1M return
- -
- +0.92%
- 1Y return
- -
- +25.35%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 0
- 14
- Recent ratings
- 0
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest ELIQ
- SEC Form 25-NSE filed by Electriq Power Holdings Inc.
- Electriq Power Holdings, Inc. Announces Chapter 7 Bankruptcy Filing
- Electriq Power Wins 2024 CleanTech Breakthrough Award for "EMS Solution Provider of the Year"
- SEC Form NT 10-K filed by Electriq Power Holdings Inc.
- Electriq Partners with Aveyo to Drive Penetration Of Affordable Solar + Storage
- Electriq Power Announces New Partnership with The Energy Coalition to Form Sustainable Community Networks in Los Angeles County Under the PoweredUp Network Program
- Electriq Power to Present at The Microcap Conference in Atlantic City, NJ
- Electriq Power Sponsors ISNA/ESNA 2024 Solar Games
- NYSE To Commence Delisting Proceedings Against Electriq Power Holdings
- CORRECTION: Electriq Power Expects $1.3M In Sales For Q4, Reiterates 2024 Revenue Range Of $20M-$30M
Latest TMO
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)
- SVP and General Counsel Shropshire Thomas B Jr. covered exercise/tax liability with 49 shares, decreasing direct ownership by 0.81% to 6,008 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. covered exercise/tax liability with 394 shares, decreasing direct ownership by 3% to 14,391 units (SEC Form 4)
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 270 shares, decreasing direct ownership by 5% to 5,560 units (SEC Form 4)
- Chairman & CEO Casper Marc N covered exercise/tax liability with 1,257 shares, decreasing direct ownership by 1% to 122,669 units (SEC Form 4)
- VP & Chief Accounting Officer Holmes Joseph R. covered exercise/tax liability with 50 shares, decreasing direct ownership by 2% to 2,916 units (SEC Form 4)
- President & COO Pettiti Gianluca covered exercise/tax liability with 1,035 shares, sold $2,539,233 worth of shares (4,133 units at $614.38) as part of a pre-agreed trading plan and exercised 3,733 shares at a strike of $309.63, decreasing direct ownership by 6% to 23,216 units (SEC Form 4)
- Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026